Viyash Scientific Limited has made acquisition of 100% shareholding of BioForLife Italia S.r.l, a pet-care company based in Milan, Italy, for ~₹188 crore.

DSK Legal advised Viyash Scientific and Alivira Animal Health Limited, Ireland, a step-down wholly owned subsidiary of Viyash, on this acquisition.

The Firm advised inter alia, in the structuring of Transaction and relevant acquiring entity from the group structure of Viyash; drafting, review, negotiating and finalizing the share purchase agreement (SPA) and other ancillary agreements; attending in-person negotiation with the sellers to represent Viyash / Alivira in Milan, Italy; general advisory in relation to the Transaction and critical commercial agreements related to the Transaction; and assistance in completion of the transaction.  

The transaction team consisted of Jayesh Kothari (Partner), Rajlaxmi Kale (Associate Partner) and Sreedatri Dhar (Senior Associate).

BDO Italy conducted the legal, financial and tax due-diligence of BioForLife, and assisted DSK Legal with undertaking drafting, negotiation, execution and closing under the SPA as per Italian laws. 

The transaction has been completed on October 1, 2026 pursuant to the receipt of Italian FDI / Golden Power Regulations.

Viyash is a publicly listed company in India and is an integrated pharmaceutical company, having global presence and portfolio of formulations and APIs for human and veterinary use. 

BioForLife, based in Milan, Italy is engaged in marketing and distribution of products of animal health/veterinary products for companion animals and has strong network presence in European market.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.